Sai Parenteral's Limited

Sai Parenteral's Limited - pharma in Seri Lingampally, Telangana, India. FY 2026 financials and compliance.
CIN U24231TG2001PLC036043 Incorporated 12 January 2001 ROC Hyderabad HQ Seri Lingampally, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹163.64 Cr
▲ 6.00% YoY
EBITDA · FY 2025
*****
▲ 21.00% YoY
Net profit · FY 2025
*****
▲ 59.00% YoY
Authorised capital
₹25.76 Cr
Registered with MCA
Paid-up capital
₹18.45 Cr
Issued & subscribed
Open charges
₹213.36 Cr
Satisfied ₹121.89 Cr
Company age
25 yrs
Est. 2001
Employees · EPFO
235
Latest available

About Sai Parenteral's Limited

Data last updated: 09 January 2026

Sai Parenteral's Limited is a public limited company based in Seri Lingampally, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 12 January 2001, the company has been in operation for over 25 years.

Registered with ROC Hyderabad under CIN U24231TG2001PTC036043.

Capital: an authorised share capital of ₹25.76 Cr and a paid-up capital of ₹18.45 Cr. Formerly known as Sai Parenteral'S Private Limited. It is led by directors including Kalidindi Venkateswara Raju and Bhagyashri Dharmasa Zad.

Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: Seri Lingampally, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹163.64 Cr, a growth of 6% compared to the previous year.

The company has a workforce of approximately 235 employees as per the latest available data.

The company is associated with 1 brand - Sai Parenterals. As per MCA filings, the company has open charges of ₹213.36 Cr and satisfied charges of ₹121.89 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saiparenterals.com.

Company Details of Sai Parenteral's Limited
CIN U24231TG2001PLC036043
Registration Number 036043
Incorporation Date 12 January 2001
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Anil Kumar Karusala Managing Director Vijitha Gorrepati Whole-Time Director Kalidindi Venkateswara Raju Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Plot No 39 5Th Floor, Lavanya Arcade Jayabheri Enclave Gachibowli, Seri Lingampally, Telangana, India – 500032
  • Industry
    Pharma, Drug Formulation & Development
Company report
Sai Parenteral's Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sai Parenteral's Limited report

Financials, compliance, directors, charges, ownership and filings for Sai Parenteral's Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Sai Parenteral's Limited

Sai Parenteral's Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231TG2001PLC036043, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24231TG2001PLC036043 Current
U24231TG2001PTC036043 Previous
U24231AP2001PTC036043 Previous

Associated Brands with Sai Parenteral's Limited

Sai Parenteral's Limited operates one associated brand: SAI Parenterals. These brands represent Sai Parenteral's Limited's diversified market presence and brand portfolio.

Brand Description Website
SAI Parenterals
Parenteral products including sterile injections and pharmaceutical services are provided. saiparenterals.com

Business Activity of Sai Parenteral's Limited

Sai Parenteral's Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Board of Directors of Sai Parenteral's Limited

Sai Parenteral's Limited is currently managed by 9 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Kalidindi Venkateswara Raju
Also directs: Scripture Meditech Private Limited, Narayana Infra Projects India Limited, Sri Ganesh Satya Sai Finance Agencies Private Limited and 1 more
Director 12 Nov 2024 1 Years 7 Months Current
Bhagyashri Dharmasa Zad
Also directs: Revat Laboratories Private Limited, Ecoboard Industries Limited
Director 01 Jan 2024 2 Years 6 Months Current
Aruna Karusala
Also directs: Revat Laboratories Private Limited
Director 16 Aug 2016 9 Years 10 Months Current
Anil Kumar Karusala
Also directs: Revat Laboratories Private Limited, Aanandi Hotels & Resorts Private Limited, Sp Analytics Private Limited
Managing Director 19 Nov 2021 4 Years 7 Months Current
Seeta Ram Anjaneyulu Gorantla Director 01 Jan 2024 2 Years 6 Months Current
Vijitha Gorrepati
Also directs: Revat Laboratories Private Limited, Sp Analytics Private Limited, Phyto Chem (India) Limited
Whole-Time Director 16 Aug 2016 9 Years 10 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Sai Parenteral's Limited FY 2025 filings available

Sai Parenteral's Limited reported revenue of ₹163.64 Cr (up 6% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹163.64 Cr ▲ 6%
Profit
***** ▲ 59%
EBITDA
***** ▲ 21%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Sai Parenteral's Limited

Open charges
₹213.36 Cr
Satisfied charges
₹121.89 Cr
Breakdown by lending institutions
Others₹105.51 Cr
Axis Bank Limited₹61.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹24.25 Cr
Hdfc Bank Limited₹20.00 Cr
Sidbi₹2.60 Cr
Latest charge details
DateLenderAmountStatus
17 Dec 2025 Others ₹38 Cr Open
11 Dec 2025 Axis Bank Limited ₹61 Cr Open
08 Dec 2025 The Hongkong and Shanghai Banking Corporation Limited ₹1.25 Cr Open
29 Aug 2025 Others ₹20 Cr Open
30 Oct 2024 Others ₹47.51 Cr Open

Total charge records: 39 View all charges

Employees and EPFO Compliance at Sai Parenteral's Limited

View historical data on people associated with Sai Parenteral's Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Sai Parenteral's Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Sai Parenteral's Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Sai Parenteral's Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Sai Parenteral's Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Sai Parenteral's Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Sai Parenteral's Limited

MSME Payment Delays by Sai Parenteral's Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Sai Parenteral's Limited

Subsidiaries & Group Companies of Sai Parenteral's Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sai Parenteral's Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Sai Parenteral's Limited

MCA Filings & Documents of Sai Parenteral's Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Sai Parenteral's Limited

Charges
17 Dec 2025
A charge with Others amounted to Rs. 38.00 Cr with Charge ID 101210350 was registered on 17 Dec 2025.
Charges
11 Dec 2025
A charge with Axis Bank Limited amounted to Rs. 61.00 Cr with Charge ID 101210375 was registered on 11 Dec 2025.
Charges
08 Dec 2025
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 1.25 Cr with Charge ID 101206434 was registered on 08 Dec 2025.
Charges
03 Oct 2025
A charge with Others of Rs. 20.00 Cr registered on 29 Aug 2025 with Charge ID 101149137 was modified on 03 Oct 2025.
Directors
01 Oct 2025
Anil Kumar was appointed as a Cfo on 01 Oct 2025 & has been associated with this company since 9 months 9 days.
Activity
27 Sep 2025
Sai Parenteral'S Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.

Frequently Asked Questions about Sai Parenteral's Limited

Sai Parenteral's Limited is an active public limited company in the pharma sector based in Seri Lingampally, Telangana, India. It was incorporated on 12 January 2001 (25+ years old) and is registered under CIN U24231TG2001PLC036043. The company has 235 employees.

Sai Parenteral's Limited reported revenue of ₹163.64 Cr for FY 2025 (up 6.00% YoY).

The current directors of Sai Parenteral's Limited are:

The primary industry of Sai Parenteral's Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Sai Parenteral's Limited can be reached at the registered office: Plot No 39 5Th Floor, Lavanya Arcade Jayabheri Enclave Gachibowli, Seri Lingampally, Telangana, India – 500032, or through the website saiparenterals.com.

The authorised capital is ₹25.76 Cr, and the paid-up capital is ₹18.45 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available